Over at The Personal Genome, Jason Bobe blogs about keeping biological data for non-clincial purposes separate from data for medical reasons, and lists some reasons. One, both physicians and regulators are already overburdened; two, restrictions on genetic testing presents problems regarding individual autonomy; and three, standardizing tests clinically puts an "unfair burden on individuals who may want to specifically avoid clinical implications of genetic sequence data."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.